Avanos Medical Inc Cash Flow-to-Debt Ratio
Avanos Medical Inc cash flow-to-debt ratio. Avanos Medical Inc (AVNS) has a Cash Flow-to-Debt Ratio of -0.05x as of March 2026, meaning its operating cash flow of $-12.30 Million could theoretically repay 0% of its total liabilities ($268.00 Million) in one year. Check how high is Avanos Medical Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Avanos Medical Inc (2012–2025)
Cash flow-to-debt ratio of Avanos Medical Inc from 2012 to 2025. Historical debt coverage capacity for Avanos Medical Inc across 14 annual periods. Check AVNS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Avanos Medical Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Avanos Medical Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Avanos Medical Inc. For the full cash flow conversion analysis, see AVNS cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | $74.70 Million | $295.50 Million | ▼ -18.2% |
| 2024 | 0.31x | $100.70 Million | $325.70 Million | ▲ +335.2% |
| 2023 | 0.07x | $32.40 Million | $456.10 Million | ▼ -61.3% |
| 2022 | 0.18x | $90.90 Million | $495.70 Million | ▼ -30.1% |
| 2021 | 0.26x | $87.30 Million | $333.00 Million | ▲ +4465.5% |
| 2020 | -0.01x | $-2.50 Million | $416.30 Million | ▲ +95.7% |
| 2019 | -0.14x | $-74.50 Million | $534.40 Million | ▲ +48.7% |
| 2018 | -0.27x | $-145.60 Million | $536.20 Million | ▼ -284.6% |
| 2017 | 0.15x | $144.20 Million | $980.50 Million | ▼ -24.5% |
| 2016 | 0.19x | $188.80 Million | $969.30 Million | ▲ +88.6% |
| 2015 | 0.10x | $97.60 Million | $944.90 Million | ▼ -27.6% |
| 2014 | 0.14x | $147.90 Million | $1.04 Billion | ▼ -74.2% |
| 2013 | 0.55x | $223.80 Million | $404.90 Million | ▲ +30.5% |
| 2012 | 0.42x | $202.60 Million | $478.50 Million | — |